SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-028623
Filing Date
2019-05-10
Accepted
2019-05-10 16:11:56
Documents
77
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7739_110q.htm 10-Q 1371294
2 EX-31.1 a19-7739_1ex31d1.htm EX-31.1 12600
3 EX-31.2 a19-7739_1ex31d2.htm EX-31.2 12576
4 EX-32.1 a19-7739_1ex32d1.htm EX-32.1 5387
5 EX-32.2 a19-7739_1ex32d2.htm EX-32.2 5425
  Complete submission text file 0001104659-19-028623.txt   7255787

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20190331.xml EX-101.INS 1864738
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20190331.xsd EX-101.SCH 57392
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20190331_cal.xml EX-101.CAL 61599
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20190331_def.xml EX-101.DEF 161899
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20190331_lab.xml EX-101.LAB 500911
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20190331_pre.xml EX-101.PRE 338184
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 19815029
SIC: 2834 Pharmaceutical Preparations